...
【24h】

Changing pattern of end-stage renal disease in central and eastern Europe.

机译:中欧和东欧终末期肾脏疾病的变化模式。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The epidemiology of end-stage renal disease (ESRD) is changing all over the world. Particularly dramatic changes of the epidemiology of ESRD have occurred in central and eastern Europe (CEE). The aim of the present study was (i) to document the further expansion of renal replacement therapy (RRT) noted in recent years in CEE and (ii) to analyse in some detail treatment modalities and underlying renal conditions. METHODS: Three independent surveys were performed in 1995, 1997 and 1998. Fifteen CEE countries participated. The data were mainly obtained from national registries which are based on centre and patient questionnaires. RESULTS: The data collected from 15 CEE countries document further expansion of RRT in this region. The report includes data on the availability of RRT in Byelorussia, Estonia, and Russia which have become available for the first time. The epidemiology of dialysed patients has changed remarkably. In the majority of countries the number of diabetic patients has increased, most dramatically so in the Czech Republic (31% of all dialysed patients), in the majority of the other countries 10-14%. The number of ESRD patients with the diagnosis of hypertensive nephropathy has also increased and this was accompanied by an increase in proportion of elderly (>65 years) patients, i.e. 46% in the Czech Republic and 12-25% in most other countries. CONCLUSION: Dramatic changes of the availability of RRT treatment have occurred in central and eastern Europe. The proportion of diabetic nephropathy and elderly patients has risen. Large differences in RRT exist between individual CEE countries and this appears mainly dependent on the level of economic development.
机译:背景:终末期肾病(ESRD)的流行病学在世界范围内正在发生变化。在中欧和东欧(CEE),ESRD的流行病学尤其发生了戏剧性的变化。本研究的目的是(i)记录近年来在CEE中注意到的肾脏替代疗法(RRT)的进一步扩展,以及(ii)详细分析治疗方式和潜在的肾脏疾病。方法:在1995年,1997年和1998年进行了3次独立调查。有15个中东欧国家参加。数据主要来自国家注册中心,该中心基于中心和患者调查表。结果:从15个中欧和东欧国家收集的数据证明了RRT在该地区的进一步扩展。该报告包括有关首次在白俄罗斯,爱沙尼亚和俄罗斯提供RRT的数据。透析患者的流行病学已发生显着变化。在大多数国家中,糖尿病患者的数量有所增加,在捷克共和国(占所有透析患者的31%)最为明显,在其他大多数国家中,这一比例为10-14%。被诊断为高血压肾病的ESRD患者人数也有所增加,与此同时,老年(> 65岁)患者的比例也有所增加,即捷克共和国为46%,其他大多数国家为12-25%。结论:RRT治疗的可用性发生了戏剧性的变化,发生在中欧和东欧。糖尿病肾病和老年患者的比例上升。在各个中东欧国家之间,RRT差异很大,这似乎主要取决于经济发展水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号